Abstract
Introduction: Systemic lupus Erythematosus (SLE) patients are inherently at risk for infections. Steroids and other immunosuppressants used for treating SLE patients further increase the chances of infections. This study was done to find the association of immunosuppressants with the risk of development of infections in patients with SLE. Materials and Methods: Appropriate samples were collected from 110 SLE patients with various infections and processed in Microbiology laboratory. Treatment history was also collected from the patients and analysis was done on infections in these patients. Results: Daily prednisolone dosage 20 mg was associated with increased risk of infection with p value of p value Conclusion: Since there is strong association between higher dose of steroids and Cyclophosphamide therapy with risk of infections in SLE patients, judicious use of these drugs is recommended.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
